Is Sanjay Gupta involved with Neurocept?
Executive summary
Available reporting shows Sanjay Gupta is not involved with Neurocept and has publicly denounced the use of his likeness in AI-generated ads that promote bogus health products (see CNN reporting) [1]. Multiple consumer complaints and independent write-ups allege Neurocept ads use deepfakes of Gupta and other public figures; those reports conclude the endorsements are fake, not authored or approved by Gupta [2] [3].
1. What the record says: Gupta publicly disavows AI ads
CNN published a clear report in which Dr. Sanjay Gupta says scammers are using his likeness in AI deepfake videos and doctored images to sell bogus health cures and fake products; he explicitly speaks out against the practice [1]. That statement from Gupta is the most direct and authoritative public denial in the available material [1].
2. Consumer complaints and watchdog-style reporting point to fake endorsements
Independent sites and consumer complaint posts document Neurocept marketing that features polished video ads presenting Gupta — and other recognizable figures — as endorsers of a “honey recipe” or pill that claims implausible benefits. Those write-ups conclude the videos are part of a bait-and-switch scam and say there is no genuine endorsement from Gupta [2] [3].
3. The specific allegation: deepfake videos and recycled scripts
Reporting describes Neurocept ads as emotional, highly produced videos that present a scripted narrative (the “honey recipe” reversal claim) and then pivot to selling a supplement. The same video template reportedly reappears with different celebrity faces, which is consistent with the mechanics of deepfake-driven ad fraud [2] [3].
4. Evidence quality and limits
The sources available are a mainstream news report (CNN) documenting Gupta’s denunciation [1], a consumer-complaint example recounting an order experience with Neurocept ads [3], and an investigative-sounding blog piece concluding the product is a scam propped up by deepfake ads [2]. These sources document the problem and Gupta’s disavowal but do not include court filings, company statements from Neurocept, or technical forensic reports proving which videos were AI-generated. Those documents are not found in current reporting (available sources do not mention court filings or technical forensics).
5. Why this matters: trust, regulation and financial harm
The combination of hijacked trust (using a high-profile medical reporter’s face) and direct-to-consumer health claims poses public-safety and consumer-protection risks, according to the accounts cited. The CNN piece frames this as a broader phenomenon of scammers leveraging AI to sell bogus health cures; the blog and complaint detail the financial harm to buyers who paid for expensive supplements after seeing such ads [1] [2] [3].
6. Alternative viewpoints and possible counterclaims
Available reporting does not include any verified statement from the makers of Neurocept claiming a legitimate endorsement by Gupta nor any evidence that Gupta ever participated. The Neurocept side of the story is not presented in these sources (available sources do not mention a response from Neurocept). Without that, alternative explanations — such as licensed use, parody, or deceptive resale of old footage — are not documented in the cited material.
7. Practical takeaways for readers
Treat ads that show familiar public figures making extraordinary health claims with skepticism; CNN’s coverage demonstrates that even respected medical journalists can have their image misused [1]. Consumer posts and investigative write-ups advise verifying endorsements directly with the purported endorser or through trustworthy outlets before buying costly products advertised in viral videos [2] [3].
Limitations: this analysis relies only on the three provided items. There may be further reporting, technical forensics, legal actions, or statements by the seller that would add important detail; those are not present in the current sources (available sources do not mention subsequent legal actions or company statements).